-
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
(PAR-20-043)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
-
NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed)
(PAR-20-045)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is Feb 5, 2020.
-
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
(PAR-20-046)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 16, 2020.
-
Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 Clinical Trial Not Allowed)
(PAR-20-048)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): July 15, 2020; July 15, 2021; July 15, 2022.
-
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
(PAR-20-049)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is February 12, 2020.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
(PAR-20-050)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is February 12, 2020.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)
(PAR-20-052)
National Cancer Institute
Application Receipt Date(s): February 24, 2020; June 24, 2020; October 20, 2020; February 24, 2021; June 24, 2021; October 20, 2021; February 24, 2022; June 24, 2022; October 20, 2022
-
Leadership Award for Alzheimer's Disease and Related Dementias Research (R35 Clinical Trial Not Allowed)
(RFA-AG-21-007)
National Institute on Aging
Application Receipt Date(s): June 19, 2020
-
Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional)
(RFA-DA-20-022)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
(RFA-DK-19-020)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 26, 2020
-
Limited Competition for the Closeout of the SEARCH for Diabetes in Youth Cohort Study (R01 Clinical Trial Not Allowed)
(RFA-DK-19-507)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 19, 2020
-
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
(RFA-ES-20-002)
National Institute of Environmental Health Sciences
Application Receipt Date(s): January 21, 2020; December 4, 2020
-
Limited Competition: Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19 Clinical Trial Not Allowed)
(RFA-MH-20-325)
National Institute of Mental Health
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 9, 2020
All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional)
(RFA-MH-20-326)
National Institute of Mental Health
Application Receipt Date(s): February 13, 2020
No late applications will be accepted for this Funding Opportunity Announcement.
-
Dysregulation and Proximal Risk for Suicide (R01 Clinical Trial Optional)
(RFA-MH-20-327)
National Institute of Mental Health
Application Receipt Date(s): February 13, 2020
No late applications will be accepted for this Funding Opportunity Announcement.
-
Miner Safety and Health Training Program - Western United States (U60)
(RFA-OH-20-001)
National Institute for Occupational Safety and Health
Application Receipt Date(s): January 31, 2020; December 01, 2020
Electronically submitted applications must be submitted no later than 5:00 p.m., ET.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.